Klaus Mayer

Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia.

J. Gabrilove, M. Andreeff, J. Kolitz, 1991, Blood.